Key words: folimycin/concanamycinA/intracellular translocation of glycoproteins/vacuolar-type ATPase/vesicular stomatitis virus/the Golgi apparatus ABSTRACT. Folimycin (concanamycin A) specifically inhibited vacuolar-type ATPase as far as examined. Folimycin blocked excretion of the glycoprotein (G protein) of vesicular stomatitis virus into the medium and, instead, G protein was accumulated intracellularly.
Glycoproteins synthesized on the rough endoplasmic reticulum (rER) are intracellularly translocated to their ultimate sites of residence via the Golgi (19) . These processes are mediated by repeated cycles of budding and fusion of vesicles (21) . N-Linked oligosaccharides are transferred en bloc from lipid intermediate to the asparagine residues of the nascent peptide in the lumen of the rER. The oligosaccharide moiety is processed sequentially during its intracellular translocation and matures in the distal site of the Golgi apparatus (ll). The mechanismsof intracellular translocation of glycoproteins have been studied in many laboratories. In Abbreviations: BHK, baby hamster kidney; BFA, brefeldin A; Con A, concanavalin A; Endo * To whomcorrespondence should be addressed.
vitro reconstitution of interorganelle transport and analysis of yeast secretion mutants have revealed some essential components and functions in intracellular transloca- tion (21) . In addition to these methods, specific inhibitors would be expected to aid in analysis of the mechanisms of intracellular translocation of glycoproteins.
To find the inhibitors of intracellular translocation of glycoproteins, we have searched for inhibitors that block cell-surface expression of viral glycoprotein without affecting its synthesis using a novel screening method. Folimycin (concanamycin A) was found in this screening study (16) . Folimycin was initially isolated as an antifungal antibiotic (32) . After this discovery, folimycin and the related compoundswere isolated as inhibitors of the proliferation of mousesplenic lymphocytes stimulated by concanavalin A (Con A) (9). Folimycin belongs to a class of 18-membered macrocyclic lactons and has a six-membered hemiketal ring with 2-deoxy-/3-D-rhamnosyl group as a substituent (Fig. 1) (9) . Wefound folimycin is a specific inhibitor of vacuolar-type ATPase (V-ATPase) among proton-translocating ATPase (H+-ATPase) and inhibits acidification of H2CH3 Fig. 1 . Structure of folimycin (concanamycin A) (9).
organdies in cultured cells as described in this paper.
During the course of these studies, it was reported that folimycin inhibits ATP dependent acidification of lysosomal vesicle in vitro (31). V-ATPase is localized amongvarious intracellular organelles participating in trafficking of glycoproteins such as endosomes, lysosomes and the trans Golgi network, and the interior of these organelles is maintained acidic by the action of . Perturbation of the acidic pH is well known to result in blocking of trafficking of glycoproteins or missorting of lysosomal enzymes (14) . Specific inhibitors of V-ATPase, such as bafilomycins, have an effect on the endocytic pathway (17) (28) or the targeting of enzyme to lysosome (18). These inhibitors can be used as pH-perturbants for investigation of physiological acidity of subcellular organelles instead of other pHperturbants that inherently have side effects, such as ionophores and lipophilic weak bases (14) . The role of V-ATPase in intracellular translocation of glycoproteins can be revealed by these specific inhibitors of V-ATPase. In this paper, we report the effect of folimycin, a specific V-ATPase inhibitor, on intracellular translocation of viral glycoprotein.
MATERIALS AND METHODS
Reagents. Folimycin isolated from a culture broth of an actinomycete was dissolved with dimethylsulfoxide or methanol and stocked at -20°C. Proteinase K was obtained from Boehringer MannheimBiochemicals (Mannheim, Germany). ATPaseassay. Vacuole and plasma membranefractions of Saccharomyces cerevisiae X-2180-1A were prepared as described by Uchida et al. (27) and Serrano (23) , respectively. Mitochondrial membranefractions were prepared from Saccharomyces cerevisiae X-2180-1A and rat liver. Saccharomyces cerevisiae cultured in the medium containing 2%sodiumlactate, 1% yeast extract and 2%polypeptone for 14 h.
The cells were incubated in the buffer containing 100 mM Tris-HCl (pH 7.6), 1.4 M sorbitol, 0.02% NaN3 and 10 mMdithiothreitol for 5 min, and subsequently incubated in the enzyme solution containing 50mMTris-HCl (pH 7.6), 1.4M sorbitol, 0.02% NaN3 and 250 /ig/ml zymolyase 100T for 30 min. Spheroplasts were suspended in the buffer containing 10 mMTris-HCl (pH7.4), 0.25M sucrose, 1 mMEDTAand 0.05% bovine serum albumin, and homogenized by Dounce homogenizer. The homogenate was centrifuged at 2,500 g for 10 min, and the supernatant was centrifuged at 40,000 g for 20 min. The pellet was used as a yeast mitochondrial fraction. Rat liver was homogenized in the buffer containing 0.25 Msucrose, 0.2M KC1 and 100mMTris-HCl (pH7.4) by glassteflon homogenizer. The homogenate was centrifuged at 700 g for 10 min, and the supernatant was centrifuged at 7,000 g for 15 min. The pellet was layered on top of 30-50% sucrose gradient, and centrifuged at 100,000 g for 3 h. The fractions containing NaN3-sensitive ATPasewere collected as mitochondrial fractions. Vacuole, mitochondria or Na+/K+-ATPasewas pre-incubated with or without folimycin at 35°C for 30 min. Plasma membrane was pre-incubated with or without folimycin in reaction buffer supplemented with NaN3 (2 mM) for 30 min on ice to inactivate other ATPases. Reactions were performed for 30 min at 35°C in the reaction buffer containing 50 mM Tris-HCl (pH7.6), 0.1 M NaCl, 15mM KC1, 5 mMMgCl2, 2 mMEDTAand 50 mMATP, and inorganic phosphate liberated from ATP was quantified. Analysis ofvirusproteins. BHKcells grown on a 96-well multiplate (Nunclon, Roskilde, Denmark) were infected with VSVat an input multiplicity of about 10 PFU/cell. After 2 h of incubation at 37°C, the mediumwas replaced with methio-nine-restricted (1.5 //g/ml) medium with or without folimycin. After 1 h, [35S]methionine (0.37 MBq/ml) was added to the cultures and the cultures were further incubated for 2 h. The labeled cells were chased for 1 h in the presence of excess nonlabeled methionine (150 //g/ml) and cycloheximide (1 ptg /ml). The VSVproteins in cellular and mediumfractions were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) using 10% acrylamide gel according to the method of Laemmli (12) .
Preparation of the VSVG glycopeptide. Monolayer cultures of BHKcells in 800 ml flasks (Nunclon, Roskilde, Denmark) were infected with VSVat an input multiplicity of about 10 PFU/cell. After 2 h of incubation at 37°C, the medium was replaced with glucose-restricted (0. 1 mg/ml) medium with or without folimycin (1.16 jjM). After 1 h, [3H]mannose (0.37 MBq/ml)was added to the cultures and the cultures were further incubated for 2 h. The labeled cells were chased for 2 h in the presence of excess nonlabeled glucose and mannose (0.5 mg/ml each). The media were put into test tubes and centrifuged at 1,500 rpm for 5 min to remove cell debris. The cell layers were treated with 10mMEDTAand monodispersed cells were collected by centrifugation at 1,500 rpm for 5 min. Proteinous materials were precipitated by adding chloroform/methanol (1/1 , v/v). After washing 3 times with chloroform/methanol/water (1/1/0.3, v/v/v) to remove [3H]mannose-labeled lipid products, they were suspended in 0.5 ml of PBS and boiled at 100°C for 5 min to inactivate endogenous degradation enzymes. Glycopeptides were prepared by treating the delipidated materials with 1 mg/ml of proteinase K for 24 h at 37°C in the presence of0.02% NaN3. To make the proteolytic degradation complete, 50 p\ of 10 mg/ml proteinase K was added and incubated further for 24 h. The protease treatment was terminated by boiling at 100°C for 5 min. Glycosidase digestion. Treatment with Endo H or exoglycosidases was performed in 50 mMsodium citrate buffer (pH 5.5) containing 0.02% NaN3 for 18 h at 37°C. The concentration of Endo H or^-mannosidase was 0.1 U/ml. The concentration of the other glycosidases was 5 U/ml. Bio-Gel P-4 column chromatography and high-performance liquid chromatography (HPLC). Glycopeptides or oligosaccharides were analyzed by Bio-Gel P-4 column chromatography (1 x 120 cm) eluted with 0.3% acetate at a flow rate of 7 ml/h and collected in 1 ml fractions. Radioactive peak fractions indicated in the text were collected and concentrated by lysophilization. Endo H-released oligosaccharides were analyzed by HPLC using Glyco-Pak N column (Waters, Milford, MA) eluted with acetonitrile/water (70 : 30, v/v) at a rate of 1 ml/min. One milliliter fractions were collected and radioactivity was counted. Mixed high-mannose oligosaccharide standards of Endo Link Kit (Genzyme, Boston, MA) were used as authentic standards.
Assay ofmannosidase I activity in vitro.
[3H]Mannose-labeled oligosaccharide, Man8GlcNAc, was prepared from folimycin-treated and VSV-infected cells. VSV-infected BHK cells were metabolically labeled with [3H]mannose as de-scribed above, and Endo H-liberated oligosaccharides were fractionated by Bio-Gel P-4 column chromatography. Microsomes of BHKcells were used as a crude enzyme source. BHK cells were incubated at 37°C for 1 h in the presence or absence of folimycin (1 fiM) and collected with a rubber policeman. The cells homogenized by a glass-teflon homogenizer were centrifuged at 600 g for 10 min to remove cell debris, and microsomes were obtained by centrifugation at 100,000 g for 2 h. Reactions were performed in 300 [A of the reaction buffer containing 50mM sodium phosphate (pH6.5), 5 mMMgC^, 0.1% Triton X-100, 0.02% NaN3 and [3H]mannose labeled Man8GlcNAc (4300-1400 dpm) at 37°C and terminated by boiling at 100°C for 3 min. Oligosaccharides in reaction mixture were analyzed by Bio-Gel P-4 column chromatography, or radioactivity of [3H]mannose passed through Con A-agarose columns (500^1) was counted.
Fluorescence microscopy. VSV particles were purified from the culture medium of VSV-infected BHKcells as described by Kelley et al. (8) and G protein was extracted with phosphate buffer containing Triton X-1 14 (20). Rabbits were immunized with the G protein and IgG was prepared from the antiserum.
BHKcells were plated on glass coverslips. Overnight sparse cultures were infected with VSV. After incubation for 1 h at 37°C, folimycin (1 ptM) was added to the cultures. The cells were further incubated for 1 h. Cycloheximide (1 //g/ml) was added to the cultures, and they were further incubated. The cells were fixed overnight in PBS containing 3% paraformaldehyde (w/v) and then washed with PBS containing 10 mMglycine. The cells were permeabilized for 5 min in methanol or PBS containing 0.1% Triton X-100 and treated with PBS containing 0.5% bovine serum albumin to exclude nonspecific absorption. We first exposed the cells to anti-G antibody (1 fig/ml) for 1 h and washed with PBS. Subsequently the cells were exposed to FITC-conjugated secondary antibody (50 fig/m\) for 1 h and washed with PBS. The coverslips were mounted onto glass slides in 90% glycerol, 100 mMTris-HCl (pH 7.2). Photographs were obtained using a fluorescent microscope (Nikon). For double fluorescence staining with lectins and anti-G antibody, we exposed the fixed cells to nonlabeled lectin (200 //g/ml) for 10 min in phosphate buffer to saturate any surface binding sites of lectins. The cells were permeabilized with PBS containing 0.1% Triton X-100 and then exposed sequentially to rhodamine-conjugated lectins (1 /*g /ml), anti-VSV IgG and FITC-conjugated secondary antibody.
RESULTS
Folimycin is a specific inhibitor of V-A TPase among H+-ATPases. Various organdies residing in endocytic and exocytic pathways such as the distal cisternae of the Golgi apparatus, endosome and lysosome are acidified. Acidification of organelles holds a pivotal function in intracellular trafficking of proteins (14). Acridine orange is a weak base and accumulates in acidic organelles. In control cells acidic organelles were stained with this probe ( Fig. 2A) , but in the presence of folimycin the cells were not stained ( Fig. 2B) , indicating that folimycin inhibits acidification of organelles. H+-ATPasesare classified into three types (6) and sensitivity to folimycin of H+-ATPases and N+/K+-ATPase was examined (Table I) . Vacuole fraction prepared from Saccharomyces cerevisiae was used as a source of V-ATPase. IC50 of folimycin for V-ATPase was 9.2 nM, but F-type and P-type H+-ATPases were not inhibited even at 20 fiM. These results indicate that folimycin is a specific inhibitor of V-ATPase and inhibition of V-ATPase is the cause of the inhibition of organelle acidification.
Folimycin inhibits intracellular translocation of envelope glycoprotein of VSV. Virus glycoprotein has served as an excellent model system for studying the biosynthesis, processing and intracellular translocation of integral membrane proteins (2). VSVis a useful tool because cellular macromolecularsynthesis is shut off after virus infection and only one virus-derived glycoprotein, G protein, is synthesized (29). To elucidate the effect of folimycin on synthesis and intracellular translocation of G protein, the VSV-codedproteins were analyzed by SDS-PAGE.Synthesis of the VSV-coded proteins was not affected by folimycin essentially. In the control, G protein was released into the mediumfraction and greatly diminished in the cell fraction after 1 h of chase ( Fig.  3, lanes 8 and 16) . However, in the presence of folimycin, release of G protein into the mediumfraction was greatly diminished above the concentration of 1.16 nM (Fig. 3, lanes 9-13) and, instead, G protein was accumulated in the cell fraction ( Fig. 3, lanes 1-5) . The non-structural virus protein (NS) was not detected in the medium fractions, indicating that release of G protein into the control mediumfraction is not a consequence of cytopathic effect of VSV multiplication. The G protein accumulated in folimycin-treated cells was resistant to proteinase K added extracellularly (16) . This result indicates that folimycin blocks cell-surface expression of G protein.
The G protein accumulated in the presence of folimycin electrophoresed a little faster than the mature one excreted into the medium (Fig. 3, compare lanes 1-5 with lane 16), suggesting that N-glycans of the G protein accumulated in the presence of folimycin are immature. N-Glycansreceive various modifications during trafficking to the cell surface (ll). Thus it was suggested that folimycin blocks intracellular translocation of glycoprotein at the latest before reaching the trans Golgi network where the processing of N-glycans is completed. Analysis of the N-glycan of the G protein accumulated intracellularly in thepresence offolimycin. Cellsurface expression of G protein was shown to be blocked in the presence of folimycin as described above. The next goal of the present research is to decide the step(s) where intracellular translocation of glycoprotein is halted. N-glycans transferred to the polypeptide moiety from the lipid-intermediate in the rER receive various modifications during trafficking en route to the cell surface via the Golgi. These processings take place at defined compartments, and the step(s) of blockade can be deduced by analyzing the structure of N-glycans (1 1). Thus we examined the structure of N-glycan of the G protein accumulated in folimycin-treated cells. The structure of N-glycan of the G protein accumulated in the presence of folimycin was characterized by sensitivity to the action of endoglycosidase H (Endo H) . The N-glycan moiety of VSVwas metabolically labeled with [3H]mannose in the presence or absence of folimycin. Cell and medium fractions were digested thoroughly with proteinase K and treated with Endo H. These fractions were analyzed by Bio-Gel P-4 column chromatography. The glycopeptides of the control medium fraction were eluted in two relatively broad peaks on BHKcells were incubated in the presence (B) or absence (A) of folimycin (1 fiM) for 1 h. Acridine orange was added to the cells and incubated for 30 min. The cells were observed by fluorescent microscopy. Bar, 10//m. V type Yeast vacuole membrane (H+-ATPase) 9.2 F type Yeast mitochondria membrane (H+-ATPase) >20,000 Rat liver mitochondria membrane (H+-ATPase) >20,000 P type Yeast plasma membrane (H+-ATPase) >20,000 Na+/K+-ATPase of porcine brain > 20,000 Yeast vacuoles, yeast mitochondria, rat liver mitochondria and yeast plasma membranewere prepared, and release of inorganic phosphate from ATPwas measured as described under Materials and Methods.
Bio-Gel P-4 column chromatography, but the main peak eluted first was Endo H-resistant ( Fig. 4A , fractions 65-80). The G protein of the New Jersey serotype of VSVis knownto contain some high-mannose type oligosaccharides (7). Thus the peak eluted later was sensitive to the action of EndoH. However, only one peak corresponding to the later peak of the control was detected in the case of the folimycin-treated cell fraction (Fig. 4B, fractions 82-105) . It was totally sensitive to the action of Endo H, and gave a sharp major peak ( Fig. 4B , peak I, fractions 100-107) and two minor peaks (Fig. 4B , peaks II and III, fractions 108-110 and 111-114) after the treatment. 78.2% of radioactivity was found in peak I, ll.1% in peak II and 10.1% in peak III. This result indicates that G protein having high-mannose type N-glycan is accumulated intracellularly in the presence of folimycin. The major N-glycan liberated by Endo H-treatment from the G protein accumulated in the presence of folimycin ( Fig. 5B , fractions 102-109) was digested sequentially with several exoglycosidases. In the case of treat- shifted at all ( Fig. 5C and D) , indicating that the N-glycan contains neither galactose nor N-acetylglucosamine residues at the non-reducing end. a-Mannosidase liberated 87.2% of [3H]mannose (Fig. 5E ). After treatment with /3-mannosidase, the first eluted peak in Fig. 5E (fractions 137-142) disappeared and only free mannose peak was detected (Fig. 5F) , indicating that N-glycan having Man/3l-4GlcNAcwas eluted in the fractions of the first eluted peak in Fig. 5E . The ratio of radioactivity in fractions 137-142 to that of free mannose (fractions 155-163) in Fig. 5E was about 1 : 6.8. These results indicate that the main N-glycan has a structure of Man8GlcNAc2.
To confirm the composition, we analyzed Endo Hreleased oligosaccharides prepared from folimycintreated cells in Fig. 4 (peaks I, II and III) by HPLC.
Mixed high-mannose oligosaccharide standards of Endo Link Kit (Genzyme) were used as authentic standards. Main peak I indicated in Fig. 4B was eluted at the same fractions as the standard of Man8GlcNAc (Fig.   61 ). Peak II and III were eluted at the position of Man7GlcNAc and Man6GlcNAc, respectively ( Fig. 611  and III) . These observations strongly support that the main structure of the N-glycan of the G protein accumulated in folimycin-treated cells is Man8GlcNAc2which 60 160
Fraction Number out the possibility of inhibition of mannosidase I, we examined the effect of folimycin on this enzyme activity in vitro. As a substrate, [3H]mannose-labeled Man8GlcNAcwas prepared from VSV-infected and folimycin-treated cells. Golgi mannosidase I is a membrane associated enzyme (26). Thus microsome fraction of BHKcells was used as a crude enzyme source. After the reaction, the size of oligosaccharide was analyzed by Bio-Gel P-4 column chromatography (Fig. 7A) , or release of [3H]mannose was measured with Con A affinity column chromatography (Fig. 7B) . Only Man5GlcNAc was detected on Bio-Gel P-4 column chromatography when Man8GlcNAc was incubated with the microsome fraction prepared from false-treated control cells (Fig.  7A I) , indicating that the liberation of [3H]mannose is caused by mannosidase I. The same result was obtained even whenmicrosomewas prepared from folimycintreated cells and the reaction was carried out in the presence of 5 [JtM folimycin, a concentration about 1,000fold higher than the minimuminhibitory concentration of cell surface expression of G protein (Fig. 7A II) . No significant difference was observed with the activity of mannosidase I as shown in Fig. 7B . In addition, folimycin did not inhibit transfer of sialic acid, galactose and sis thereafter at 1 h of the treatment. At 3 h after the infection, intracellular Gprotein wasdetected with both the control (Fig. 8A) and folimycin-treated cells (Fig.   8C ). During the chase in the presence of cycloheximide, the intracellular Gprotein in the control cells disappeared mostly (Fig. 8B) . In contrast to the control, G protein halted intracellularly in the presence of folimycin ( Fig. 8D ) and its distribution did not change during the chase period (compareFig. 8Cand D). Theseresults are in good agreementwith those on SDS-PAGE ( Fig.  3) and rule out the possibility that folimycin inhibits the release of the Gprotein expressedon the cell surface i n t o t h e m e d i u m . Lectins recognize oligosaccharides specifically and someof themstain definedcompartment(s) in mammalian cells (1). Doublefluorescence staining with lectins and anti-G antibody wasemployed.Wheatgermagglutinin (WGA) stains the trans cisternae of the Golgi and the trans Golgi network. ConA, that binds high-mannose type oligosaccharides, is thought to stain the ER and the cis compartment of the Golgi. WGA stained relatively large intracellular areas, but the organelle(s) stained with anti-G antibody wasscarcely stained with this lectin (indicated by arrows in Fig. 9A and B) . On the contrary, anti-Gstaining occupiedthe areas stained strongly with Con A (compare Fig. 9C and D) . TheGolgi and in the cis Golgi networksare redistributed to the ERin the presence of brefeldin A (BFA) VSV-infected and folimycin-treated BHKcells were fixed at 4 h after the infection and permeabilized in PBS containing 0. 1%Triton X-100 as described in the legend to Fig. 8 . The cells were exposed to either rhodamine-conjugated WGA(B) or rhodamine-conjugated Con A (D) and subsequently exposed anti-G antibody followed by FITC-conjugated second antibody (A and C). The cells were prepared for indirect fluorescence staining. Arrows indicate the position where G protein accumulated in folimycin-treated cells. Bar, 10 fim.
(13) (15) . The effect ofBFA on the distribution of G protein in folimycin-treated cells was examined. VSV-infected and folimycin-treated cells were cultured further for 1 h in the presence or absence of BFA. The cells were fixed and the G protein localized in the cells was stained with anti-G antibody. WhenBFAwas added to the folimycin-treated cells, the structure, in which G protein was accumulated, disappeared and reticular networks characteristic of the ERwere stained (Fig. 10B ). This result suggests that egress of Gprotein from the ER takes place in folimycin-treated cells.
DISCUSSION
Glycoproteins play diverse but important functions in eukaryotic cells. Muchattention has been focused recently on the mechanismsof intracellular translocation of glycoproteins from the site of synthesis to the sites where they exert their respective functions. To elucidate the details of these mechanisms, various devices have been developed including secretion mutants and in vitro assay systems (21) . It should be easily anticipated that specific inhibitors of intracellular translocation would greatly aid in elucidating the trafficking mechanisms. BFAis a representative of such inhibitors and interesting observations have been accumulated since our discovery of its novel action (24). But very restricted specific inhibitors are nowavailable. Wehave searched for inhibitors that block cell-surface expression of glycoprotein and found folimycin in this search (16) . Synthesis and intracellular translocation of viral glycoproteins have been studied as a model of membrane glycoprotein trafficking (2). VSVwas employed to examine the effects of folimycin on intracellular translocation of glycoprotein. The amount of G protein released into the mediumfraction was greatly diminished in the presence of folimycin above 1.16 nM (Fig. 3) . The possibility that folimycin blocks release of G protein from Folimycin Folimycin Folimycin Folimycin + Brefeldin A Fig. 10 . Effect ofBFAon the distribution of the VSVG protein accumulated in folimycin-treated cells. BHKcells were infected with VSVand treated with folimycin (1 fiM) as described in the legend to Fig. 8 . BFA (5 //g/ml) was added (B) or not added (A) to the cells at 4 h after the infection, and the cells were further incubated for 1 h. The cells were fixed, permeabilized and prepared for indirect immunofluorescence staining. Bar, 10 //m. the cell surface without affecting its cell-surface expression was excluded by the following observations. Extracellularly added proteinase K digested the G protein expressed on the cell surface of control cells, but the cell-associated G protein synthesized in the presence of folimycin was resistant to this treatment (16) . Whenthe fate of the intracellular G protein was followed by indirect immunofluorescencetechnique, no significant decrease of the intracellularly accumulated Gprotein was observed on chase in the presence of folimycin and cycloheximide while a great diminution was detected with the control cells (Fig. 9 ).
The degree of inhibition of the release of nucleocapsid protein (N) and matrix protein (M) into the medium fraction was not so profound as that of G protein (Fig.  3) . A similar result was obtained with BFA(unpublished observation).
In the latter case, virus particles without G protein were found to be formed as analyzed by sucrose density gradient centrifugation. Taken together, the release of N and M proteins into the medium in the presence of folimycin suggests that various aspects of virus multiplication proceed nearly normally in the presence of folimycin except the cell-surface expression of G protein.
The G protein accumulated intracellularly in the presence of folimycin migrated a little faster than the control mature one on SDS-PAGE (Fig. 3) . Compared lane 13 with lanes 14 and 16, a significant amount of the G protein having a similar mobility as the intracellularly accumulated one was released into the medium.This was not caused by the destruction of cells, because the amount of the liberated G protein increased proportionally to the decrease of folimycin concentration, and release of non structural NSprotein into the mediumwas not detected. This suggests the presence of an exocytic pathway which is relatively insensitive to the action of low dose folimycin. The cell-associated G protein accumulated in the presence of folimycin was sensitive to Endo H (Fig. 4) . The elution position of the Endo H-liberated oligosaccharides on Bio-Gel P-4 column chromatography was not influenced by sequential digestion with /3-galactosidase and N-acetylhexosaminidase (Fig. 5B, C and D) . a-Mannosidase liberated most of the mannoseresidues from the oligosaccharide, and the ratio of radioactivity in fractions from 137 to 142 (4261 dpm) to fractions from 155 to 163 (48941 dpm)was about 1 : 6.8 (Fig. 5E ). The mannoseresidues were converted nearly completely to monosaccharide after /3-mannosidase treatment (Fig.  5F) . The ratio of a-mannosidase-sensitive mannose residues to that of resistant ones indicates that the Endo-H liberated oligosaccharide has mainly the composition of Man8GlcNAc. This was confirmed by HPLC( Fig. 6 ).
Folimycin did not inhibit mannosidase I (Fig. 7) and glycosyltransferase (data not shown) as far as examined.
Deoxymannojirimycin and swainsonine, inhibitors of mannosidase, do not block cell-surface expression of viral glycoproteins (4) (5). Taken together the blockade of processing of oligosaccharide moiety of Gprotein is not the cause but a result of inhibition of exocytic trafficking. The sites of processing of N-glycan are confined to defined intracellular organelles and thus, usually, the structure of N-glycan reflects intracellular translocation. This criterion has been often employed as a proof, and the acquisition of Endo H-resistance in translocation from the ER to the Golgi and the N-acetylglucosamine transfer in translocation from the cis to the medial compartment of the Golgi are the representatives of such proofs (1 1). According to the criterion the intracellular translocation of G protein is blocked before entry into the cis compartment of the Golgi apparatus where the oligosaccharide of Man8GlcNAc2is processed to Man5GlcNAc2 by mannosidase I. The compartment(s) where VSVG protein accumulated in the presence of folimycin was (were) co-stained by Con A but not by WGA (Fig. 9 ). This is in good agreementwith the results of oligosaccharide analysis. OnBFAtreatment, the structure where G protein accumulated in the presence of folimycin disappeared and, instead, reticular networks characteristic of the ER were stained (Fig. 10) . Cumulatively it is suggested that G protein egresses from the ER but its trafficking en route to the cell surface is blocked before the cis compartment of the Golgi. Electron microscopic observa-tion did not reveal accumulation of transition vesicles, but large membranousstructures and virus-like particles therein were observed (data not shown). Coronavirus particle formation takes place in the cis Golgi networks (25). This compartment is one of the most plausible sites of blockade by folimycin, but the decision of the precise site of blockade awaits further studies.
Wefound that folimycin inhibits V-ATPase specifically among H+-ATPases as shown in Table I . During the course of the present study inhibition of ATP-dependent acidification of lysosomal vesicles in vitro was reported (3 1), but specific inhibition of V-ATPase activity was directly indicated here. Bafilomycins are representatives of specific V-ATPase inhibitors (3). Bafilomycins have been reported to inhibit endocytosis of diphtheria toxin (28), recycling of LDL receptor (17) and targeting of lysosomal enzymes (18), but, to our knowledge, this is the first indication of inhibition of exocytosis of glycoproteins synthesized de novo by V-ATPase inhibitor.
Mistargeting of lysosomal soluble enzymes and their extracellular secretion in the presence of bafilomycins meanthat exocytic pathway of these proteins from the ER to the cell surface functions satisfactorily, except the sorting in the trans Golgi network. Among lysosomal enzymes, targeting of soluble enzymeswas more sensitive than that of membrane-boundenzymes to the action of bafilomycin Ai (10). Wehave no answer to the discrepancy between the sensitivity to V-ATPase inhibitors in trafficking of lysosomal enzymes and of virus membrane glycoproteins. The possibility that the inhibition of intracellular translocation observed with folimycin is caused by a hitherto unraveled action of this antibiotic other than the inhibition of V-ATPasecan be ruled out, but not exclusively, by the following observa- during the screening of inhibitors of intracellular translocation of viral glycoproteins (unpublished observations). Intraorganellar acidification is well known with lysosomes, endosomes and the trans Golgi network (14). These organelles reside after the Golgi in the flow of the intracellular trafficking and, to our knowledge, luminal acidification has not been reported with organelles resided before the Golgi. But an ATPase in the ER has characteristics similar to those of V-ATPase(22). Binding of peptides having KDELsequence to its receptor, which is localized in the ER and the cis Golgi network, is pHdependent and is more effective at acidic pH range than neutral (30). Specific inhibitors of these V-ATPases would aid in unraveling their unknown functions.
